Company profile
Nouscom
Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.
- Location
- Basel, Basel-Stadt, Switzerland, Europe
- Website
- nouscom.com
Latest known funding
Series D round
- Capital
- $134.7M
- Announced
- Oct 19, 2026